Hybrid Competitive Intelligence Analyst, Oncology

Caris Life Sciences; Irving (TX); Hybrid; USD 90,000 - 140,000; Full time

Job summary

Caris Life Sciences seeks a Competitive Intelligence Analyst, Oncology Diagnosis, to generate actionable intelligence on NGS-based oncology diagnostics and the competitive landscape. The role informs Commercial, Marketing, Medical Affairs, and R&D with evidence-based recommendations.

The analyst will synthesize publications, trials, and market data, track developments in genomic profiling and precision oncology, and deliver regular updates and targeted analyses to shape strategy.

Qualifications

• Bachelor's degree in life sciences, molecular biology, genetics, or related field.
• 3+ years of oncology diagnostics market analysis, competitive intelligence, or equivalent.
• Ability to assess diagnostic evidence and its strategic implications with strong analytical skills.
• Proficiency in Excel and PowerPoint; ability to synthesize scientific information for diverse audiences.

Responsibilities

• Critically evaluate publications, trials, and data to assess assay performance and clinical utility.
• Track oncology CI landscape: competitor test launches, pricing, reimbursement, and partnerships.
• Develop intelligence reports, dashboards, and concise insights for leadership across Commercial, Marketing, Medical Affairs, and R&D.
• Collaborate with Medical Affairs, R&D, and Market Access to support positioning and evidence generation.

Skills

Analytical thinking

Scientific writing

Presentation skills

Project management

Education

Bachelor's degree in life sciences or related field

Tools

Excel

PowerPoint

Regulatory databases

Job description

Caris Life Sciences seeks a Competitive Intelligence Analyst, Oncology Diagnosis, to generate actionable intelligence on NGS-based oncology diagnostics and the competitive landscape. The role informs Commercial, Marketing, Medical Affairs, and R&D with evidence-based recommendations.

The analyst will synthesize publications, trials, and market data, track developments in genomic profiling and precision oncology, and deliver regular updates and targeted analyses to shape strategy.